Magallanes, Ladelyn .
HRN: 22-78-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2025
CEFUROXIME 500MG (TAB)
06/22/2025
06/29/2025
PO
1 Tab
BID
SP NSVD W RMLE
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: